Clinical Trial Update: The Effect of an Oral Supplement,TK3 (Tryptophan and Thiamine) on the Quality of Life and Chemotherapy Tolerance in Cancer Patients With Advanced Disease. [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial assessing the oral supplement TK3 (tryptophan and thiamine) for improving quality of life and chemotherapy tolerance in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TK3 (Tryptophan and Thiamine) (Tryptophan and Thiamine)

Snippet

Sponsor: Faculdade de Medicina do ABC | Conditions: Cancer, Quality of Life | Phase 2 | Status: UNKNOWN